Page last updated: 2024-08-21

oxazoles and Arrhythmias, Cardiac

oxazoles has been researched along with Arrhythmias, Cardiac in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19902 (15.38)18.7374
1990's5 (38.46)18.2507
2000's2 (15.38)29.6817
2010's3 (23.08)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Azam, MA; Bouly, M; Chakraborty, P; Lai, PFH; Massé, S; Nanthakumar, K; Niri, A; Riazi, S; Thollon, C1
Cox, H; De Avezedo, V; Egazaryan, L; Ferlazzo, G; Furin, J; Hewison, C; Hughes, J; Isaakidis, P; Jonckheere, S; Kalon, S; Khachatryan, N; Laxmeshwar, C; Mohr, E; Shroufi, A1
Gao, F; Hu, M; Zheng, C1
Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T; Yamanaka, H; Yamatodani, A1
Chen, K; Chen, SR; Cheng, H; Obayashi, M; Shimoni, Y; Ter Keurs, H; Walsh, MP; Xiao, B; Yang, D; Zhong, G1
Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T; Yamatodani, A1
Chakŭrova, L; Pulev, A; Staneva, D1
Hayashi, Y; Kamibayashi, T; Mammoto, T; Takada, K; Yamatodani, A; Yoshiya, I2
Bousquet, P; De Jong, W; Feldman, J; Monassier, L; Roegel, JC; Yannoulis, N1
Lada, W1
Bousquet, P; Feldman, J1
Dua, PR; Kohli, RP; Rastogi, SK; Singh, N; Sinha, JN1

Reviews

3 review(s) available for oxazoles and Arrhythmias, Cardiac

ArticleYear
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Aged; Animals; Antitubercular Agents; Arrhythmias, Cardiac; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diarylquinolines; Drug Interactions; Drug Monitoring; Humans; Hypoglycemic Agents; Middle Aged; Nitroimidazoles; Oxazoles; Polypharmacy; Risk Assessment; Risk Factors; Tuberculosis

2016
[Imidazoline receptors and use of drug blocking receptors I1].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1996, Volume: 1, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Antihypertensive Agents; Arrhythmias, Cardiac; Cimetidine; Histamine H2 Antagonists; Humans; Hypertension; Imidazoles; Myocardial Infarction; Oxazoles; Rilmenidine

1996
Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.
    Drugs, 1999, Volume: 58, Issue:5

    Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Failure; Humans; Hypertension; Imidazoles; Imidazoline Receptors; Oxazoles; Receptors, Drug; Rilmenidine

1999

Other Studies

10 other study(ies) available for oxazoles and Arrhythmias, Cardiac

ArticleYear
Effects of azumolene on arrhythmia substrate in a model of recurrent long-duration ventricular fibrillation.
    Biochemical and biophysical research communications, 2022, 04-16, Volume: 600

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Imidazoles; Oxazoles; Rabbits; Ventricular Fibrillation

2022
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.
    The Lancet. Infectious diseases, 2018, Volume: 18, Issue:5

    Topics: Adult; Antitubercular Agents; Armenia; Arrhythmias, Cardiac; Cohort Studies; Diarylquinolines; Drug Therapy, Combination; HIV Infections; Humans; India; Nitroimidazoles; Oxazoles; Retrospective Studies; South Africa; Tuberculosis, Multidrug-Resistant

2018
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway and endogenous nitric oxide are needed for the antiarrhythmic effect of centrally administered rilmenidine.
    European journal of pharmacology, 2010, Nov-25, Volume: 647, Issue:1-3

    Topics: Androstadienes; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephrine; Halothane; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxazoles; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Rilmenidine; Signal Transduction; Sympathomimetics; Wortmannin

2010
Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts.
    The Biochemical journal, 2006, May-15, Volume: 396, Issue:1

    Topics: Adrenergic beta-Agonists; Animals; Arrhythmias, Cardiac; Benzylamines; Blotting, Western; Calcium Signaling; Carrier Proteins; Cell Line; Cyclic AMP-Dependent Protein Kinases; Heart Failure; Humans; Ion Channel Gating; Ion Transport; Isoproterenol; Kidney; Marine Toxins; Mice; Myocytes, Cardiac; Oxazoles; Peptide Fragments; Phosphoprotein Phosphatases; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rabbits; Rats; Recombinant Fusion Proteins; Ryanodine Receptor Calcium Release Channel; Sodium-Calcium Exchanger; Staurosporine; Structure-Activity Relationship; Sulfonamides; Transfection

2006
The antiarrhythmic effect of centrally administered rilmenidine involves muscarinic receptors, protein kinase C and mitochondrial signalling pathways.
    British journal of pharmacology, 2008, Volume: 153, Issue:8

    Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephrine; KATP Channels; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxazoles; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Rilmenidine

2008
[Pharmacological study of 3-alkyl-5-(cycloalkoxymethyl)oxazolidines].
    Eksperimentalna meditsina i morfologiia, 1982, Volume: 21, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cats; Drug Evaluation, Preclinical; Heart Rate; Lethal Dose 50; Mice; Mice, Inbred Strains; Oxazoles; Propranolol

1982
Rilmenidine prevents epinephrine-induced arrhythmias in halothane-anesthetized dogs.
    Journal of cardiovascular pharmacology, 1995, Volume: 26 Suppl 2

    Topics: Adrenergic alpha-Agonists; Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Halothane; Imidazoline Receptors; Male; Oxazoles; Receptors, Drug; Rilmenidine

1995
Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
    British journal of pharmacology, 1996, Volume: 117, Issue:8

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Anesthetics, Inhalation; Animals; Arrhythmias, Cardiac; Blood Pressure; Dogs; Epinephrine; Female; Halothane; Heart Rate; Idazoxan; Imidazoline Receptors; Male; Oxazoles; Receptors, Drug; Rilmenidine; Yohimbine

1996
Inhibition of centrally induced ventricular arrhythmias by rilmenidine and idazoxan in rabbits.
    Naunyn-Schmiedeberg's archives of pharmacology, 1996, Volume: 354, Issue:5

    Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Bicuculline; Blood Pressure; Dose-Response Relationship, Drug; GABA Antagonists; Heart Rate; Idazoxan; Injections, Intravenous; Male; Oxazoles; Rabbits; Rilmenidine

1996
An experimental investigation on the antiarrhythmic activity of antiepileptic agents.
    Japanese journal of pharmacology, 1971, Volume: 21, Issue:6

    Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Arrhythmias, Cardiac; Coronary Vessels; Dogs; Electrocardiography; Epinephrine; Female; Ligation; Male; Oxazoles; Phenytoin; Quinidine; Trimethadione

1971